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Background: Although Indigenous Australians are over-represented among heroin users, there has been no
study examining offending, time in custody, and opioid substitution therapy (OST) treatment utilisation among
Indigenous opioid-dependent (including heroin) people at the population level, nor comparing these to non-Indigenous
opioid-dependent people. The aims of this study were to compare the nature and types of charges, time in custody and
OST treatment utilisation between opioid-dependent Indigenous and non-Indigenous Australians in contact with the
criminal justice system.
Methods: This was a population-based, retrospective data linkage study using records of OST entrants in New South
Wales, Australia (1985–2010), court appearances (1993–2011) and custody episodes (2000–2012). Charge rates per 100
person-years were compared between Indigenous and non-Indigenous Australians by sex, age and calendar year.
Statistical comparisons were made for variables describing the cumulative time and percentage of follow-up time spent
in custody, as well as characteristics of OST initiation and overall OST treatment utilisation.
Results: Of the 34,962 people in the cohort, 6,830 (19.5%) were Indigenous and 28,132 (80.5%) non-Indigenous. Among
the 6,830 Indigenous people, 4,615 (67.6%) were male and 2,215 (32.4%) female. The median number of charges per
person against Indigenous people (25, IQR 31) was significantly greater than non-Indigenous people (9, IQR 16) (p < 0.001).
Overall, Indigenous people were charged with 33.2% of the total number of charges against the cohort and 44.0% of all
violent offences. The median percentage of follow-up time that Indigenous males and females spent in custody was
twice that of non-Indigenous males (21.7% vs. 10.1%, p < 0.001) and females (6.0% vs. 2.9%, p < 0.001). The percentage
of Indigenous people who first commenced OST in prison (30.2%) was three times that of non-Indigenous people (11.2%)
(p < 0.001). Indigenous males spent less time in OST compared to non-Indigenous males (median percentage of follow-up
time in treatment: 40.5% vs. 43.1%, p < 0.001).
(Continued on next page)* Correspondence: n.gisev@unsw.edu.au
1National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New
South Wales, Australia
Full list of author information is available at the end of the article
© 2014 Gisev et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Gisev et al. BMC Public Health 2014, 14:920 Page 2 of 16
http://www.biomedcentral.com/1471-2458/14/920(Continued from previous page)
Conclusions: Compared to non-Indigenous opioid-dependent people, Indigenous opioid-dependent people in contact
with the criminal justice system are charged with a greater number of offences, spend longer in custody and commonly
initiate OST in prison. Hence, contact with the criminal justice system provides an important opportunity to engage
Indigenous people in OST.
Keywords: Indigenous population, Aboriginal and Torres Strait Islander people, Opioid-related disorders, Opioid
substitution treatment, Crime, Prisons, Data linkageBackground
Substance use is a major social and health challenge for
Indigenous peoples worldwide, and contributes to 20%
of the disease burden (in disability adjusted life years)
experienced by Aboriginal and Torres Strait Islander
(Indigenous) Australians [1]. Illicit drug use accounts for
3% of the total disease burden, and is responsible for 4%
of the disparity in health between Indigenous and
non-Indigenous Australians [1]. Indigenous people are
over-represented among samples of injecting drug
users in Australia - despite comprising about 3% of the
population [2], between 11% and 12% of respondents in a
national survey of needle and syringe program attendees
identified as Indigenous [3]. Similarly, studies in Australia
and Canada have shown that Indigenous injecting drug
users are over-represented in experiencing the harms
associated with injecting drug use, including higher
incidences of HIV and hepatitis C [4-6].
Indigenous people worldwide are known to have
contact with the criminal justice system at disproportion-
ately high levels [7,8]. About one-quarter of the prisoner
population in Australia are Indigenous [9]. The most
common charges for Australian Indigenous prisoners are
acts intended to cause injury (34%), unlawful entry with
intent (16%), and offences against justice procedures (11%)
[9]. In addition to being more likely to be arrested, charged
and imprisoned, the frequency of criminal justice contact
is higher among Indigenous people [10], and occurs at an
earlier age than non-Indigenous people [11]. About
three-quarters (77%) of Indigenous people in Australian
prisons have previously been imprisoned, compared with
51% of non-Indigenous people [9].
The factors contributing to over-representation of
Indigenous people in the criminal justice system are
complex and often inter-related [10]. Indigenous people
experienced major disruption to every aspect of health,
social, economic, cultural and spiritual systems following
colonisation, and inter-generational trauma is ongoing.
The Royal Commission into Aboriginal Deaths in Custody
in the early 1990s proposed that the over-representation
of Indigenous people in prison was due to the combined
effect of bias in the criminal justice system and Indi-
genous economic and social disadvantage [12]. The Royal
Commission recommended that Indigenous economic,social and cultural disadvantage, as well as substance
abuse, be addressed [12]. Currently, there is little evidence
to support the idea that discrimination and racial bias in
policing and court decisions explain the over-representation
of Indigenous people in prison [10,13]. After adjusting for
sentence-related factors such as current and past offending,
Indigenous people are no more likely to be issued longer
sentences than non-Indigenous people in New South Wales
(NSW) courts [14].
Alcohol abuse and illicit drug use are strongly associated
with the likelihood and number of arrests Indigenous
people have experienced in the last five years [15]. Opioid
substitution therapy (OST – methadone or buprenorphine),
the preferred treatment for opioid dependence, has shown
to be beneficial in reducing heroin use [16,17], other drug
use, crime, HIV infection, exposure to viral hepatitis, and
mortality [18]. However, maintaining retention in treatment
is necessary in order to maximise OST treatment outcomes
[19]. Higher legal severity (corresponding with more
complex and severe criminal justice histories) have been
associated with shorter retention in methadone treatment
[20]. However, there are limited data comparing out-
comes related to OST use between Indigenous and
non-Indigenous people. Ethnic minority groups have been
found to experience significant delays in admission to
methadone programs and lower retention once in
treatment [21,22]. Similar findings have been observed
among Aboriginal people in studies of people who inject
drugs in Canada [23]. In contrast, an evaluation of OST
provision in an urban Australian Aboriginal Health
Service found that rates of treatment retention and
heroin use reduction were equivalent to those observed in
mainstream treatment programs [24]. There is therefore a
clear need for further research to resolve these differences
in study findings, given the potential benefits of treatment
in this population.
To date, there has been no study examining offending,
time in custody, and OST treatment utilisation among
Indigenous opioid-dependent people at the population
level, nor comparing these to non-Indigenous opioid-
dependent people. Using a population-level cohort of
opioid-dependent people in contact with the criminal
justice system in NSW, Australia, the aims of this study
(relating to three main themes), were to:
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criminal charges for Indigenous and non-Indigenous
Australians (offending);
2. Compare the charge histories of Indigenous and
non-Indigenous Australians by sex, age and calendar
year (offending);
3. Compare the cumulative time and percentage of
follow-up time spent in custody among Indigenous
and non-Indigenous Australians (custody);
4. Compare initiation of OST treatment, overall OST
treatment utilisation, and the temporal relationship
between age of first offence and first commencing OST




The population-level cohort was defined on the basis that
individuals had a recorded history of opioid dependence
(as evidenced by the receipt of OST), at least one criminal
charge during the study period, and valid information
regarding their Indigenous identity (n = 34,962).
Data sources
Three administrative datasets were used to define the
cohort in this study and to compare patterns of offend-
ing, time in custody and opioid-substitution therapy
(OST) treatment utilisation between Indigenous and non-
Indigenous Australians.
The Pharmaceutical Drugs of Addiction System (PHDAS)
dataset
The PHDAS is a comprehensive record of all people in
NSW to whom pharmaceutical drugs of addiction were
dispensed by authorised clinicians through the NSW
Opioid Treatment Program since 1985. The PHDAS re-
cords each client’s full name, date of birth, sex, OST
program entry and exit dates, the OST medicine re-
ceived (buprenorphine or methadone), the approved pre-
scriber, the treatment setting (community or prison) and
the reason for program exit [25]. A new treatment pro-
gram is recorded in the PHDAS when an application to
prescribe OST is approved by the NSW Ministry of
Health, or if a client changes their prescriber, OST medi-
cine, or point of administration. A person can therefore
have multiple treatment programs during a period of con-
tinuous dosing. Consistent with earlier studies, a continu-
ous OST treatment program was defined where there was
less than seven days between program exit dates and sub-
sequent program entry dates [26,27].
The Re-offending Database (ROD)
The ROD is a database maintained by the NSW Bureau of
Crime Statistics and Research (BOCSAR) that containsrecords of all finalised court appearances (i.e. all court
matters that are completed and have an outcome) in the
Local, District and Supreme Courts of NSW since 1994
and custody episodes from the NSW Department of
Corrective Services from 2000. Specifically, the ROD was
used to extract data relating to all offences occurring
between 1 December 1993 and 31 December 2011 and
custody episodes which occurred between 1 January 2000
and March 2012. The internal matching process of the
ROD dataset has been previously validated and identified to
have a specificity of 99.9% and a sensitivity of 93.8% [28].
The National Death Index (NDI)
The NDI is a fully identified dataset held by the Australian
Institute of Health and Welfare (AIHW) which contains
mortality records (date, State, and causes of death) collected
from each of the State and Territory Births, Deaths and
Marriage Registers across Australia. Date of death was used
to terminate the follow-up period for individuals who died
prior to the end of coverage in the datasets.
Definitions
Receipt of OST was used as a marker of opioid dependence,
which is a clinical criterion for receiving treatment with
OST in NSW. We assumed ongoing opioid dependence
from first entry to OST to the end of follow-up, as it is
known that opioid dependence is a chronic relapsing
disorder with low remission rates [29,30].
The term Indigenous in this paper refers to individuals
who identify as Australian Aboriginal and/or Torres
Strait Islander people. An individual was considered
Indigenous if they were ever-identified as an Aboriginal
and/or Torres Strait Islander person in either the ROD or
PHDAS datasets (determined by self-report). Therefore,
individuals with conflicting records (who were identified
as Indigenous in one dataset and non-Indigenous in the
other) were also considered as Indigenous. Records for
people with an unknown/missing Indigenous identity
were excluded from the cohort (n = 13,107).
Offending was evaluated using data relating to charges
(recorded crime) and were coded according to the
Australian and New Zealand Standard Offence Classification
(ANZSOC) system which has 16 major categories of
offences [31]. This study used definitions consistent with
the BOCSAR’s standard crime and statistic reporting [32].
Violent offences included murder, assault, robbery, sexual
assault and indecent assault/act of indecency/other sexual
offences. Property offences included break and enter, motor
vehicle theft, theft and fraud.
Statistical analyses
Through the linkage of the datasets described, this study
provided a unique opportunity to conduct longitudinal
population-level analyses. All analyses were conducted
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NC, USA). Descriptive statistics were used to summarise
charges, time in custody and OST treatment utilisation.
Comparisons between Indigenous and non-Indigenous
Australians in the cohort were made using chi-square tests
of association for categorical variables and Wilcoxon-
Mann-Whitney tests for continuous variables. Due to the
different date ranges available for the each of the datasets,
we defined distinct follow-up periods to determine the
total observation period for each analysis, taking into
account the date of death (if recorded).
Offending
The follow-up time for the analyses of charges commenced
on 1 December 1993, or whenever the individual turned 10
years of age (whichever was later); 10 years is the age of
criminal responsibility in NSW. Follow-up ceased on 31
December 2011, or when death occurred (whichever was
earlier). In addition to comparisons of offence frequencies,
rates of charges per 100 person years (PY) were also
calculated for Indigenous and non-Indigenous males and
females, by age group, and calendar year to determine if
rates varied across age groups and over time.
Time in custody
The follow-up time for the analyses of custody episodes
commenced on 1 January 2000, or whenever the participant
turned 10 years of age (whichever was later). The follow-up
time ceased on 31 March 2012, or when death occurred
(whichever was earlier). Custody episodes where the
individual was received and released on the same day were
excluded. In calculating the duration of custody episodes,
both complete and incomplete custody episodes were
included. Complete custody episodes were those completely
contained within the follow-up period (i.e. reception date of
or after 1 January 2000 and release date of or before 31
March 2012). Incomplete custody episodes were those
which started prior to January 1 2000 and/or had not ended
by 31 March 2012. In these cases, only days within the
follow-up period were counted. The percentage of total
follow-up time each individual spent in custody was
compared using the cumulative time spent in custody
(including incomplete episodes) and the total length of
follow-up (start of custody to 31 March 2012 or death).
OST treatment utilisation
The follow-up time for analyses relating to OST treatment
utilisation commenced on the day of OST initiation (with
records from 1 January 1985) and ended at death or the
date of data extraction (18 May 2012), whichever was earl-
ier. Individuals who had commenced treatment and had
no treatment end date listed, were deemed to still be re-
ceiving treatment at the date of extraction. Treatment re-
tention was evaluated at three, six, nine and 12 monthsafter first commencing OST and compared between Indi-
genous and non-Indigenous offenders. The percentage of
total follow-up time each individual spent in treatment
was compared using the cumulative time spent in treat-
ment and the total length of follow-up (start of treatment
to 18 May 2012 or death).
Temporal relationship between age of first offence and
first commencing OST treatment
In order to examine the temporal relationship between
age of first charge and first commencing OST treatment,
we identified a sub-set of individuals from the total
study population who were below the age of criminal
responsibility in NSW (10 years) at the beginning of
the charges dataset (1 December 1993) (n = 2,815).
We therefore had their complete criminal charge histories
and were able to analyse these in relation to their first
OST commencement.
Ethical approval
Ethical approval to conduct this study was obtained
from the ethics committees of the NSW Aboriginal
Health and Medical Research Council (AH&MRC),
University of New South Wales, NSW Health’s Population
& Health Services Research Ethics Committee, the AIHW,
the Alfred Hospital (Victoria), Corrective Services NSW,
Justice Health and Forensic Mental Health Network
(NSW Health), and the Department of Justice (Victoria).
Results
Of the 34,962 individuals in the cohort, 6,830 (19.5%) were
Indigenous; 4,615 (67.6%) were male and 2,215 (32.4%)
were female (Table 1). Among the 28,132 individuals in
the cohort who were non-Indigenous, 20,179 (71.7%) were
male and 7,953 (28.3%) were female (p < 0.001).
Offending
A total of 210,593 charges were laid against Indigenous
offenders, and 424,203 charges were laid against non-
Indigenous offenders (Table 1). The median number of
charges for Indigenous offenders (25, IQR 31) was almost
three times that of non-Indigenous offenders (9, IQR
16) (p < 0.001), indicating that repeat offending was com-
mon. The percentage of charges which were proven (i.e.
those with a guilty verdict) was similar between Indi-
genous and non-Indigenous males (83.5% vs. 85.6%) and
females (87.3 vs. 88.4%) (Additional file 1). Charges for
theft and related offences were the most prevalent, repre-
senting 23.9% of all charges by Indigenous offenders and
24.9% of all charges by non-Indigenous offenders. Prop-
erty offences represented 25.0% of all charges for both
Indigenous and non-Indigenous offenders. However,
the percentage of charges for a violent offence was
greater among Indigenous offenders (14.9%) than
Table 1 Charge histories of opioid-dependent people with at least one criminal charge according to Indigenous status,
December 1993-December 2011
Among people charged at least once Indigenous (N = 6,830) Non-Indigenous (N = 28,132) Total (N = 34,962)
Males 4,615 (67.6%) 20,179 (71.7%) 24,794 (70.9%)
Females 2,215 (32.4%) 7,953 (28.3%)* 10,168 (29.1%)
Median no. charges (IQR) (Min-Max) 25 (31) (1–175) 9 (16) (1–314)# 11 (21) (1–314)
Median no. proven charges (IQR) (Min-Max)
Among all charged 21 (27) (0–166) 8 (15) (0–301)# 9 (18) (0–301)
Among those who had any proven charge 21 (27) (1–166) 8 (15) (1–301) # 10 (18) (1–301)
N (%) charges by major crime types
Homicide and related offences 144 (0.1%) 262 (0.1%) 406 (0.1%)
Acts intended to cause injury 27,647 (13.1%) 35,490 (8.4%) 63,137 (10.0%)
Sexual assault and related offences 590 (0.3%) 739 (0.2%) 1,329 (0.2%)
Dangerous or negligent acts endangering persons 3,834 (1.8%) 10,498 (2.5%) 14,344 (2.3%)
Abduction, other offences against the person 1,204 (0.6%) 1,597 (0.4%) 2,801 (0.4%)
Robbery, extortion and related offences 3,010 (1.4%) 3,554 (0.8%) 6,564 (1.0%)
Unlawful entry/burglary, break and enter 13,169 (6.3%) 20,347(4.8%) 33,516 (5.3%)
Theft and related offences 50,364 (23.9%) 105,453 (24.9%) 155,817(24.6%)
Fraud, deception and related offences 7,275 (3.5%) 23,076 (5.4%) 30,351 (4.8%)
Illicit drug offences 15,132 (7.2%) 47,903 (11.3%) 63,035 (9.9%)
Prohibited and regulated weapons offences 1,780 (0.9%) 5,111 (1.2%) 6,891 (1.1%)
Property damage and environmental pollution 9,676 (4.6%) 12,964 (3.1%) 22,640 (3.6%)
Public order offences 21,629 (10.3%) 34,999 (8.3%) 56,628 (8.9%)
Traffic and vehicle regulatory offences 27,231 (12.9%) 75,682 (17.8%) 102,913 (16.2%)
Offences against justice procedures 26,076 (12.4%) 40,940 (9.7%) 67,016 (10.6%)
Miscellaneous offences 1,832 (0.9%) 5,588 (1.3%) 7,420 (1.2%)
Charges for any property offence (N, % all charges) 52,594 (25.0%) 104,930 (25.0%) 157,524 (25.0%)
Charges for any violent offence (N, % all charges) 31,349 (14.9%) 39,962 (9.4%) 71,311 (11.2%)
Total number of charges 210,593 424,203 634,796
Total number of proven charges 177,887 365,531 543,418
Percentage of charges proven 84.5% 86.2% 85.6%
*Chi-square test, p < 0.001; # Wilcoxon-Mann-Whitney test, p < 0.001.
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and 73.5% (females) of charges for violent offences by
non-Indigenous people were proven. Similarly, between
69.6% (males) and 76.3% (females) of charges for vio-
lent offences by Indigenous people were proven.
Although Indigenous offenders comprised 19.5% of the
cohort, they contributed to 33.2% of the total charges laid
against the cohort; ranging between 24.0% (fraud and illicit
drug offences) and 45.8% (robbery and related offences)
of specific charge types (Figure 1). Considering all
violent offences, Indigenous offenders contributed to
almost half (44.0%) of all violent offence charges laid
against the cohort.
The distribution and outcomes of charges laid against
Indigenous and non-Indigenous males and females are
shown in Table 2. Among male offenders, the largestdifference in the percentage of charges laid against
Indigenous and non-Indigenous people were for offences
relating to property damage and environmental pollution
such as noise, air or water pollution (61.1% vs. 29.0%,
p < 0.001), followed by offences against justice procedures
(80.3% vs. 49.9%, p < 0.001). Among female offenders, the
largest difference in the percentage of charges laid against
Indigenous and non-Indigenous people were for offences
relating to acts intended to cause injury (62.4% vs. 29.3%,
p < 0.001), followed by offences against justice procedures
(69.8% vs. 37.8%, p < 0.001).
Figures 2 and 3 show that across age categories,
charge rates (number of charges/100 person-years)
were approximately two times greater among female and
male Indigenous offenders than non-Indigenous female
and male offenders, and were higher among younger
Figure 1 The proportion of charges laid against Indigenous offenders, December 1993- December 2011.
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females peaked at 20–24 years of age (86.1 charges/100
person-years), whereas for Indigenous females, the charge
rate was highest across two age categories - 15–19 years
(178.9 charges/100 person-years) and 20–24 years (179.6
charges/100 person-years). Conversely, charge rates for
both Indigenous and non-Indigenous males peaked at
15–19 years of age (341.8 charges/100 person-years and
144.7 charges/100 person-years, respectively). There was
an overall decline in charge rate with increasing age for
both males and females.
The charge rates (number of charges/100 person-years)
between non-Indigenous and Indigenous males and
females across the 1993–2011 calendar years are shown in
Additional files 2 and 3. For each group, charge rates were
relatively consistent across all years, with the exception of
a clear peak in overall charge rates in 2001, corresponding
with the time that a heroin shortage was observed across
Australia [33,34].
Time in custody
A total of 17,967 individuals spent at least one full day
in custody between January 2000 and March 2012, with
Indigenous people representing 5,303 (29.5%) of all
those who were incarcerated among the cohort (Table 3).
Overall, Indigenous people spent twice the median
percentage of follow-up time in custody compared with
non-Indigenous people (21.7% vs. 10.1%, p < 0.001 for
males, and 6.0% vs. 2.9%, p < 0.001 for females). Thiswas both the result of Indigenous people having more
custody episodes (median of 5 episodes for males and 4
for females), and episodes were of a longer duration
(median 75 days for males and 30 days for females). In
comparison, the median number of custody episodes for
non-Indigenous people was 3 episodes for males and 2
episodes for females; the median duration of custody
episodes was 68 days for males and 22 days for females.
OST treatment utilisation
Table 4 compares OST treatment utilisation during the
first treatment episode and in total over the follow-up
period, between Indigenous and non-Indigenous males
and females. More Indigenous offenders first commenced
OST while in custody than non-Indigenous offenders
(30.2% vs. 11.2%, p < 0.001), which was consistent among
both males (37.7% vs. 13.8%, p < 0.001) and females
(14.8% vs. 4.6%, p < 0.001).
Examining treatment retention during individuals’ first
OST treatment episode, the percentage of people in
treatment at three, six, nine and 12 months was lower
among Indigenous offenders (decreasing from 53.9% at
three months to 24.7% at 12 months) than non-Indigenous
offenders (decreasing from 58.6% at three months to 31.3%
at 12 months). Furthermore, the lower treatment retention
observed among Indigenous offenders was consistent for
both males (decreasing from 53.4% at three months to
24.0% at 12 months) and females (decreasing from 54.9% at
three months to 26.4% at 12 months).
Table 2 Outcomes of charges against opioid-dependent people with at least one criminal charge by Indigenous status and sex, December 1993-December 2011
Males (N = 24,794) Females (N = 10,168)










(N = 4,615) (N = 20,179) (N = 4,615) (N = 20,179) (N = 2,215) (N = 7,953) (N = 2,215) (N = 7,953)
Offence type N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Homicide and related offences 93 172 <0.001 56 105 <0.001 21 24 <0.001 15 17 0.001
(2.0%) (0.9%) (1.2%) (0.5%) (0.9%) (0.3%) (0.7%) (0.2%)
Acts intended to cause injury 3,655 9,585 <0.001 3,386 8,273 <0.001 1,383 2,329 <0.001 1,279 2,001 <0.001
(79.2%) (47.5%) (73.4%) (41.0%) (62.4%) (29.3%) (57.7%) (25.2%)
Sexual assault and related offences 280 369 <0.001 182 219 <0.001 18 18 <0.001 11 7 N/A
(6.1%) (1.8%) (3.9%) (1.1%) (0.8%) (0.2%) (0.5%) (0.1%)
Dangerous or negligent acts
endangering persons
1,597 5,222 <0.001 1,497 4,874 <0.001 357 1,191 0.186 338 1,117 0.149
(34.6%) (25.9%) (32.4%) (24.2%) (16.1%) (15.0%) (15.3%) (14.0%)
Abduction, other offences against
the person
694 1,026 <0.001 564 788 <0.001 124 105 <0.001 90 71 <0.001
(15.0%) (5.1%) (12.2%) (3.9%) (5.6%) (1.3%) (4.1%) (0.9%)
Robbery, extortion and related
offences
1,074 1,631 <0.001 897 1,375 <0.001 286 246 <0.001 228 202 <0.001
(23.3%) (8.1%) (19.4%) (6.8%) (12.9%) (3.1%) (10.3%) (2.5%)
Unlawful entry/burglary, break
and enter
2,597 5,694 <0.001 2,383 5,029 <0.001 685 988 <0.001 580 802 <0.001
(56.3%) (28.2%) (51.6%) (24.9%) (30.9%) (12.4%) (26.2%) (10.1%)
Theft and related offences 3,928 13,209 <0.001 3,793 12,615 <0.001 1,862 5,138 <0.001 1,826 4,914 <0.001
(85.1%) (65.5%) (82.2%) (62.5%) (84.1%) (64.6%) (82.4%) (61.8%)
Fraud, deception and related offences 1,529 5,564 <0.001 1,435 5,236 <0.001 837 2,174 <0.001 804 2,063 <0.001
(33.1%) (27.6%) (31.1%) (25.9%) (37.8%) (27.3%) (36.3%) (26.0%)
Illicit drug offences 3,231 12,382 <0.001 3,159 12,066 <0.001 1,319 3,827 <0.001 1,282 3,688 <0.001
(70.0%) (61.4%) (68.5%) (59.8%) (59.5%) (48.1%) (57.9%) (46.4%)
Prohibited, regulated weapons
offences
894 2,683 <0.001 779 2,328 <0.001 178 361 <0.001 153 292 <0.001
(19.4%) (13.3%) (16.9%) (11.5%) (8.0%) (4.5%) (6.9%) (3.7%)
Property damage, environmental
pollution
2,820 5,853 <0.001 2,626 5,215 <0.001 811 1,168 <0.001 743 1,018 <0.001
(61.1%) (29.0%) (56.9%) (25.8%) (36.6%) (14.7%) (33.5%) (12.8%)
Public order offences 3,601 9,764 <0.001 3,462 9,085 <0.001 1,424 2,696 <0.001 1,370 2,515 <0.001
(78.0%) (48.3%) (75.0%) (45.0%) (64.3%) (33.9%) (61.9%) (31.6%)
Traffic and vehicle regulatory offences 3,316 12,505 <0.001 3,284 12,314 <0.001 1,233 3,844 <0.001 1,214 3,778 <0.001




















Table 2 Outcomes of charges against opioid-dependent people with at least one criminal charge by Indigenous status and sex, December 1993-December 2011
(Continued)
Offences against justice procedures 3,706 10,073 <0.001 3,559 9,398 <0.001 1,547 3,004 <0.001 1,471 2,738 <0.001
(80.3%) (49.9%) (77.1%) (46.6%) (69.8%) (37.8%) (66.4%) (34.4%)
Miscellaneous offences 758 2,714 <0.001 675 2,367 <0.001 428 936 <0.001 380 819 <0.001
(16.4%) (13.4%) (14.6%) (11.7%) (19.3%) (11.8%) (17.2%) (10.3%)
Any property offence 3,894 12,754 <0.001 3,789 12,236 <0.001 1,821 4,990 <0.001 1,781 4,803 <0.001
(84.4%) (63.2%) (82.1%) (60.6%) (82.2%) (62.7%) (80.4%) (60.4%)
Any violent offence 3,773 10,137 <0.001 3,539 8,856 <0.001 1,434 2,440 <0.001 1,330 2,113 <0.001
(81.8%) (50.2%) (76.7%) (43.9%) (64.7%) (30.7%) (60.0%) (26.6%)
Total 33,773 98,446 – 31,737 91,287 – 12,513 28,049 – 11,784 26,042 –




















Figure 2 Number of charges against opioid-dependent people per 100 person years for non-Indigenous and Indigenous females,
according to type of offence and age group.
Figure 3 Number of charges against opioid-dependent people per 100 person years for non-Indigenous and Indigenous males, according
to type of offence and age group.
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Table 3 Profile of custody episodes1 for 17,967 opioid-dependent people according to Indigenous status,
January 2000 – March 2012
Males (N = 14,012) Females (N = 3,746)
Indigenous Non-Indigenous Indigenous Non-Indigenous










Number of custody episodes 5 6 3 4 <0.001 4 5 2 3 <0.001
1-47 1-39 1-35 1-26
Duration of custody episodes (days) 75 206 68 205 0.004 30 119 22 108 <0.001
1–6,819 1–8,348 1–5,201 1–5,341
Percentage of follow-up time each
individual spent in custody
21.7 38.2 10.1 24.0 <0.001 6.0 16.1 2.9 8.8 <0.001
0.02-100 0.02-100 0.02-100 0.02-100
1Includes incomplete episodes, i.e. days in the follow-up period spent in custody for episodes that had started prior to 2000, and/or which had not ended by
March 2012.
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number of OST treatment episodes between Indigenous
(2, IQR 3) and non-Indigenous (2, IQR 3) males (p = 0.348),
the median number of treatment episodes was greater for
Indigenous females (3, IQR 4) than non-Indigenous females
(2, IQR 3) (p < 0.001). Indigenous males spent less time
in treatment over the follow-up period compared to non-
Indigenous males (40.5% vs. 43.1%, p = 0.002). There was
no difference in time in treatment among Indigenous
females compared to non-Indigenous females (57.9%
vs. 55.8%, p = 0.885).
The temporal relationship between age of first offence
and first commencing OST treatment among the
sub-cohort of 2,815 people with full offending data
available is examined in Additional file 4. Among males,
the median age of first OST entry among Indigenous
offenders was 6.6 years after their first charge, compared
to 3.9 years among non-Indigenous offenders, a difference
of 2.7 years. Similarly, among females, the median age of
first OST entry among Indigenous offenders was 4.2 years
after their first offence, compared to 1.5 years among
non-Indigenous offenders.
Discussion
The results from this study provide the first population-
level comparison of offending, time in custody, and OST
treatment utilisation among opioid-dependent Indigenous
and non-Indigenous Australians in contact with the
criminal justice system.
Offending
Despite comprising less than one fifth of the cohort,
Indigenous Australians accounted for one third of all
charges, indicating that disproportionately more charges
were laid against Indigenous people in the cohort, and
that repeat offending was common; a finding consistent
with previous studies [10,35,36]. Theft, traffic offencesand illicit drug offences were the three most common
offence types among non-Indigenous males and females.
Conversely, among Indigenous males and females, theft,
acts intended to cause injury, and offences against justice
procedures (e.g. failing to appear before court) were
most common. Based on 2012 estimates, acts intended
to cause injury, unlawful entry with intent, and offences
against justice procedures accounted for almost 60% of
offences recorded among Indigenous Australians [37].
Therefore, compared to the broader population of
Indigenous offenders in Australia, theft was more common
among our cohort. Acquisitive crime is known to be higher
among people who use drugs as it has the potential to
generate income to support their drug use [38], a key
factor likely to be responsible for the higher rate of
theft and related offences observed in our cohort. In
addition, a history of criminal arrest may be a barrier
to gaining employment, resulting in further criminal
activity in order to generate income. It has previously
been estimated that about 15% of the difference in
employment-population rates between Indigenous and
non-Indigenous Australians is due to the difference in
arrest rates [39]. Indigenous Australians historically
experienced higher unemployment rates, lower income
and inter-generational poverty than other Australians,
and fare worse across other related social determinants of
health [40]. Also relevant to our cohort, was the peak
in the rate of charges that occurred in 2001; a direct
consequence of the heroin shortage that occurred in
Australia (most notably in NSW) during that time
[34]. The shortage led to an increase in the price of
heroin, which subsequently resulted in an increase in
the rate of acquisitive crime [33].
Indigenous people contributed to almost half (44%) of
all violent-related offences. The higher rate of violent
offending among Indigenous people is well documented
[41]. In addition, compared to non-Indigenous violent
Table 4 OST treatment utilisation among opioid-dependent offenders, by Indigenous status and sex, January 1985 – December 2010
Males (N = 24,794) Females (N = 10,168) Total (N = 34,962)
Indigenous Non-Indigenous Indigenous Non-Indigenous Indigenous Non-Indigenous
N = 4,615 N = 20,179 N = 2,215 N = 7,953 N = 6,830 N = 28,132
n % n % n % n % n % n %
(Median) (Min-Max) (Median) (Min-Max) P (Median) (Min-Max) (Median) (Min-Max) P (Median) (Min-Max) (Median) (Min-Max) P
First treatment episode
Age at treatment entry (years): 26.4 9.1 (IQR) 27.7 9.7 (IQR) <0.001 24.3 18.6 (IQR) 25.9 9.5 (IQR) <0.001 25.7 9.0 (IQR) 27.2 9.7 (IQR) <0.001
Median IQR (min-max) 14.3-60.6 14.9-73.3 14.8-49.2 14.2-63.9 14.3-60.6 14.2-73.3
OST first received: <0.001 0.168 <0.001
Methadone 4,004 86.8 16,700 82.8 1,909 86.2 6,761 85.0 5,913 86.6 23,461 83.4
Buprenorphine 611 13.2 3,479 17.2 306 13.8 1,192 15.0 917 13.4 4,671 16.6
Setting: <0.001 <0.001 <0.001
Community 2,877 62.3 17,403 86.2 1,888 85.2 7,585 95.4 4,765 69.8 24,988 88.8
Prison 1,738 37.7 2,776 13.8 327 14.8 368 4.6 2,065 30.2 3,144 11.2
Year of treatment entry: <0.001 <0.001 <0.001
1985–1990 353 7.7 3,001 14.9 266 12.0 1,342 16.9 619 9.1 4,343 15.4
1991–1995 587 12.7 3,648 18.1 337 15.2 1,453 18.3 924 13.5 5,101 18.1
1996–2000 1,204 26.1 5,991 29.7 645 29.1 2,418 30.4 1,849 27.1 8,409 29.9
2001–2005 1,212 26.3 4,438 22.0 568 25.6 1,690 21.3 1,780 26.1 6,128 21.8
2006-2010 1,259 27.3 3,101 15.4 399 18.0 1,050 13.2 1,658 24.3 4,151 14.8
Duration of episode (days): 169 560 (IQR) 206 776 (IQR) <0.001 177 657 (IQR) 288 1,001 (IQR) <0.001 172 595 (IQR) 227 843 (IQR) <0.001
Median IQR (min-max) 1–9,518 1–9,980 1–9,752 2–9,915 1-9752 1-9980
Number of people in
treatment at:
3 months 2,466 53.4 11,496 57.0 <0.001 1,216 54.9 5,001 62.9 <0.001 3,682 53.9 16,497 58.6 <0.001
6 months 1,793 38.9 8,807 43.6 <0.001 905 40.9 3,492 49.6 <0.001 2,698 39.5 12,749 45.3 <0.001
9 months 1,378 29.9 7,190 35.6 <0.001 711 32.1 3,253 40.9 <0.001 2,089 30.6 10,443 37.1 <0.001
12 months 1,106 24.0 6,050 30.0 <0.001 584 26.4 2,764 34.8 <0.001 1,690 24.7 8,814 31.3 <0.001
Overall treatment utilisation
Form of OST ever received: <0.001 <0.001 <0.001
Methadone only 2,881 62.4 12,136 60.1 1,348 60.9 5,032 63.3 4,229 61.9 17,168 61.0
Buprenorphine only 272 5.9 2,034 10.1 124 5.6 608 7.6 396 5.8 2,642 9.4




















Table 4 OST treatment utilisation among opioid-dependent offenders, by Indigenous status and sex, January 1985 – December 2010 (Continued)
Number of OST switches within
a treatment episode:
<0.001 0.001 <0.001
0 3,153 68.3 14,170 70.2 1,472 66.5 5,640 70.9 4,625 67.7 19,810 70.4
1–5 1,391 30.1 5,830 28.9 717 32.4 2,236 28.1 2,108 30.9 8,066 28.7
>5 71 1.5 179 0.9 26 1.2 77 1.0 97 1.4 256 0.9
Ever received OST in prison: <0.001 <0.001 <0.001
No 1,492 32.3 12,470 61.8 1,136 51.3 6,314 74.4 2,628 38.5 18,784 66.8
Yes 3,123 67.7 7,709 38.2 1,079 48.7 1,639 20.6 4,202 61.5 9,348 33.2
Total number of treatment
episodes:
2 3 (IQR) 2 3 (IQR) 0.348 3 4 (IQR) 2 3 (IQR) <0.001 2 3 (IQR) 2 3 (IQR) <0.001
Median IQR (min-max) 1-23 1-30 1-25 1-26 1-25 1-30
Percentage of follow-up time each
individual spent in treatment:#
40.5 58.3 (IQR) 43.1 66.6 (IQR) 0.002 57.9 59.5 (IQR) 55.8 66.5 (IQR) 0.885 45.6 60.2 (IQR) 46.5 67.3 (IQR) 0.052
Median IQR (min-max) 0.02-100 0.01-100 0.04-100 0.02-100 0.02-100 0.01-100
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http://www.biomedcentral.com/1471-2458/14/920offenders, Indigenous violent offenders are more likely
to be re-incarcerated for a violent offence, and within
shorter periods of time [41]. Multiple inter-related
factors embedded in the historical experiences of
Indigenous people are likely to contribute to their
high rates of violent offending, including for example,
loss of land and culture, trans-generational trauma,
grief and loss, and social exclusion [42]. Although
alcohol use is often a major factor implicated in violent
crimes [41,43], the relationship between illicit drug use
and violent crime is less clear. In national surveys of police
detainees and prisoners, Indigenous offenders were less
likely than non-Indigenous offenders to self-report heroin
use in the 30 days prior to being detained by police, and
also in the six months prior to imprisonment [11].
However, in a survey of drug use and crime behaviour
among male offenders incarcerated in prison, drug
markets were identified as being associated with high
levels of violence [44], with the highest being among those
whose preferred drug of choice was heroin - 29% of
respondents reported using force or threats of violence
and 17% reported using weapons to obtain heroin. Hence,
despite the various factors influencing Indigenous people
to commit violent crimes, the role of illicit drug use
cannot be excluded.
Previous studies have identified that Indigenous male
offenders tend to have earlier and more serious contact
with the criminal justice system [11]. In our cohort,
offending commenced about three years earlier among
Indigenous people. Indigenous females in particular, had
charge rates that peaked earlier and for longer (15–19 years
to 20–24 years) compared to non-Indigenous females
(20–24 years). Conversely, charge rates peaked between
15–19 years for both Indigenous and non-Indigenous
males. To date, offending patterns among Indigenous men
have been more widely studied than that of Indigenous
women [45,46]. Current evidence suggests that discrim-
ination among Indigenous women is compounded by
being both female and Indigenous, and that few criminal
justice system services and interventions are targeted to
their needs [46]. Most services are either designed for
Indigenous men, or for women in general, and are
not culturally specific [41,46]. Consequently, our results
highlight that there is a great need to further understand
and address Indigenous females’ over-representation in
the criminal justice system.
There was also a clear reduction in the rate of offending
with increasing age, particularly among Indigenous people.
The low offending rates observed beyond 65 years for
females and 69 years for males is likely to be related to
poorer health, and multiple co-morbidities experienced by
older Indigenous people, and life expectancy being only
72.9 for females and 67.2 for males - on average 13 years
less than non-Indigenous Australians [47].Time in custody
Indigenous people represented 30% of all of people
who were incarcerated among our cohort, whereas the
point-prevalent estimate of the percentage of Indigenous
people in prison in NSW in 2013 is 23% [9]. Given
that Indigenous people comprise 2.9% of the general
population in NSW [2], our findings suggest that
much of the over-representation of Indigenous people
in custody may be due to greater contact among people
who are opioid dependent. Previously we have shown that
there are marked differences in the cumulative time
spent in custody among Indigenous and non-Indigenous
opioid-dependent people [48]. In this study, Indigenous
people spent twice the median percentage of follow-up
time in custody, a consequence of these individuals having
more custody episodes, as well as episodes being of a
longer duration. This was consistent for both males and
females. Over the twelve year period between 2000 and
2011, there was a 62% increase in the age-standardised
imprisonment rate among Indigenous people in Australia
[25]. In comparison, a marginal increase of 5% was
observed among non-Indigenous people, highlighting the
extent of disadvantage experienced by Indigenous people
in contact with the criminal justice system [25]. Periods of
imprisonment carry many health risks for people who
inject drugs due to needle sharing and transmission of
blood borne viruses [49,50], potentiating risks which are
already greater among Indigenous people [5]. Therefore,
encouraging the use of OST to reduce the health risks
associated with injecting drug use is especially important
among Indigenous people who are imprisoned.
OST treatment utilisation
Recent data show that Indigenous people are over-
represented in OST in NSW [25]. We found that
Indigenous people more frequently commenced OST in
custody, which suggests under-treatment in the commu-
nity. Although not directly evaluated in our study, there is
evidence that OST treatment is associated with reduced
offending [51-53]. Given that Indigenous people in our
cohort also spent significantly more time in custody,
these findings highlight the importance of making
OST accessible through prisons. However, due to different
OST policies and programs across countries and
jurisdictions, access to OST in prisons vary widely [54].
For example, in Australia, although all eight States and
Territories offer maintenance OST in prison, only five of
these (NSW included) allow first-time initiation of OST in
prison [54]. Despite NSW having one of the largest
in-prison OST programs in Australia [55], culturally rele-
vant and accessible programs for Indigenous people in the
community are still needed.
Indigenous males were poorly retained in their first
OST treatment episode. Given that Indigenous males
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http://www.biomedcentral.com/1471-2458/14/920more frequently commenced OST treatment in prison,
poor treatment continuity at the time of release is likely
to have resulted in shorter treatment episodes. This
highlights the need for the development and implementa-
tion of evidence-based and culturally tailored interven-
tions to support the transition of Indigenous males from
prison to the community. This is important because main-
taining retention in OST is necessary to achieve optimal
OST treatment outcomes [19]. About a quarter of Indi-
genous people aged 15 years and over living in non-
remote areas report difficulty accessing health services, a
rate ten times that of the general Australian population
[56]. Although efforts have been made to close the gap in
health and disease burden between Indigenous and non-
Indigenous Australians, Indigenous men still have the
poorest health outcomes [47]. It is known that Indigenous
people are more likely to access services in prison [57], and
prisons provide an important opportunity for the provision
of health care and screening to Indigenous people that
would otherwise have difficulty accessing health services
[58]. There remains a need to further examine issues
around gender and access to OST among Indigenous
people in order to maximise treatment outcomes.
Strengths and limitations
The cohort in this study was defined on the basis that
individuals had a recorded history of opioid dependence,
recorded Indigenous status (Indigenous/non-Indigenous),
and at least one criminal charge in NSW during the study
period. Through the use of state-wide administrative
datasets, this study presented a unique opportunity to
evaluate longitudinal population-level data. Given that
NSW has the largest proportion of Indigenous residents
in Australia, and also the largest proportion of clients in
OST, a major strength of our study is that the cohort is
representative of a large number of Indigenous and
non-Indigenous opioid-dependent people in the Australian
population. However, as the provision of OST and criminal
justice services vary between States and Territories, the
findings of this study may not be the same across
jurisdictions. In addition, although the National Deaths
Index is able to capture deaths occurring in any State or
Territory in Australia, the other datasets used in this study
are NSW specific. Therefore, we are not able to capture
events that occurred outside NSW or follow those individ-
uals who might have migrated to other States or outside
Australia. Furthermore, although Australian OST services
aim to ensure access to disadvantaged populations includ-
ing Indigenous populations [59], rates of participation in
the community are not consistent across Australia [60].
Hence, the results may not necessarily be generalisable to
other Indigenous opioid-dependent populations.
Information regarding the identity of Indigenous
Australians is not always reliable in health datasets;missing data is common, and Aboriginal and Torres Strait
Islander people are often under-counted [61]. Furthermore,
estimates of disparities in health between Indigenous
and non-Indigenous people can be affected by the way
in which Indigenous identity is recorded [62]. The ever-
identified strategy used in this study meant that
Aboriginal and Torres Strait Islander people were included
despite changes in administrative data recording or
personal preference to identify as Indigenous or not
over time [63]. Although recent studies have suggested
that the application of other approaches to identify
Aboriginal or Torres Strait Islander people in datasets
may have improved accuracy [62], we were restricted
to the approach used by the data custodians in con-
structing the datasets. However, we endeavoured to
improve the accuracy of correctly identifying Indigenous
people in the cohort by triangulating information from
two data sources.
Rates of offending based on data from administrative
datasets provide estimates of the number of charges
which are made, based on offences which are reported
to correctional authorities. Consequently, offences which
are unreported are not able to be enumerated, which may
lead to an under-estimation of actual rates of offending.
Hence, the rates of offending reported in our study are also
likely to have been under-estimated. As the main purpose
of this study was to undertake a detailed comparison of
offending, time in custody, and OST treatment util-
isation among Indigenous and non-Indigenous people
in an opioid-dependent population, we did not examine
whether time in OST directly affects either offending
or time in custody, but is an important area for future
research. Also, given that we were unable to assess
the temporal relationship between time of offence and
initiation of opioid use, this presents another area for
future research.Conclusions
There are clear differences in the nature and levels of offend-
ing, as well as time spent in custody among Indigenous
and non-Indigenous people with a history of opioid de-
pendence and contact with the criminal justice system.
Indigenous populations continue to experience social
exclusion and ongoing inequity across determinants of
health and our findings highlight that Indigenous
people with opioid use disorders are further disadvan-
taged. Although the prison setting appears to be an im-
portant access point for OST among Indigenous people,
the under-treatment of Indigenous people in the commu-
nity is also apparent, and there appears to be a lack of con-
tinuity between the prison and community OST systems.
The underlying reasons for these differences therefore need
to be addressed, with a focus on the development,
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and evidence-based culturally tailored interventions.Additional files
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